RBF Capital’s Cogentix Medical, Inc. CGNT Stock Holding History

RBF Capital’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-24,500	Closed	-$24K	–	395
2016 Q2	$24K	Buy	+24,500	New	+$24.2K	﹤0.01%	365

Other funds holding CGNT

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RBF Capital's CGNT Position: Q3 2016 in Review

RBF Capital sold out of Cogentix Medical, Inc. (CGNT) in Q3 2016, closing a stake of 24,500 shares — an estimated $24K sold.

RBF Capital first reported a position in CGNT in Q2 2016 and held it in 1 quarter. The position peaked at $24K in Q2 2016. 34 funds tracked by Wall St. Rank hold CGNT as of Q3 2016.

RBF Capital reported no remaining Cogentix Medical, Inc. position as of Q3 2016 after selling out during the quarter.
RBF Capital sold 24,500 Cogentix Medical, Inc. shares in Q3 2016, an estimated $24K.
RBF Capital first reported a position in Cogentix Medical, Inc. in Q2 2016 and held it in 1 quarter.
RBF Capital's Cogentix Medical, Inc. position peaked at $24K in Q2 2016.
34 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q3 2016.

Based on RBF Capital's 13F filing for Q3 2016, filed 14 Nov 2016.